Shares of Alkem Laboratories witnessed block deals worth about Rs 930 crore on Tuesday, with promoter family entities selling shares to a clutch of domestic mutual funds and foreign institutional investors. According to NSE block deal data, a total of 17.88 lakh shares changed hands at Rs 5,200 apiece. The transaction value works out to…
Welcome to Music Business Worldwide’s weekly round-up – where we make sure you caught the five biggest stories to hit our headlines over the past seven days. MBW’s round-up is supported by Centtrip, which helps over 500 of the world’s best-selling artists maximize their income and reduce their touring costs. This week, it was reported by Bloomberg and The…
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. JPMorgan Chase and investment banking boutique Evercore have displaced Morgan Stanley as the chief rivals to Goldman Sachs in the core Wall Street business of dealmaking advice. JPMorgan generated financial advisory fees last year —…
Kontakt.io, an analytics company focusing on the inpatient healthcare journey, announced it secured $47.5 million in a Series C funding round led by Growth Equity at Goldman Sachs Asset Management (Goldman Sachs). Christian Resch, partner at Goldman Sachs, will join the company’s board of directors. WHAT IT DOES Kontakt.io uses AI and real-time Internet of…
Goldman Sachs analysts have named a slew of stocks that could see upside as April rolls in. The firm said these companies are well positioned as the second quarter gets underway. CNBC Pro combed through Goldman Sachs’ research to find the firm’s favorite stocks as of late. The names listed below are all buy rated….
